새로운 고혈압 가이드라인에 따른 고혈압 진료

참고문헌 (11)

1. Williams B, "2018 ESC", ESH guidelines for the management of arterial hypertension, 2018, pp.39, 3021~3104
2. Conen D, "Age-specific differences between conventional and ambulatory daytime blood pressure values", Hypertension, 64, pp.1073~1079 (2014)[DOI]
3. Johnson KC, "Blood pressure measurement in SPRINT (systolic blood pressure intervention trial)", Hypertension, 71, pp.848~857 (2018)[DOI]
4. Weinberger MH, "Sodium and volume sensitivity of blood pressure. Age and pressure change over time", Hypertension, 18, pp.67~71 (1991)[DOI]
5. Beckett NS, "Treatment of hypertension in patients 80 years of age or older", N Engl J Med, 358, pp.1887~1898 (2008)[DOI]
6. JATOS Study Group, "Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)", Hypertens Res, 31, pp.2115~2127 (2008)[DOI]
7. SPRINT Research Group, "A randomized trial of intensive versus standard blood-pressure control", N Engl J Med, 373, pp.2103~2116 (2015)[DOI]
8. Hughes TM, "Hypertension and its role in cognitive function: current evidence and challenges for the future", Am J Hypertens, 29, pp.149~157 (2016)[DOI]
9. Mancia G, "2013 ESH", ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), 2013, pp.31, 1281~1357
10. Williams B, "Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial", Lancet, 386, pp.2059~2068 (2015)[DOI]
11. 김현창, "Noncommunicable Diseases: Current Status of Major Modifiable Risk Factors in Korea", 예방의학회지, 46(4), pp.165~172 (2013), 대한예방의학회

관련 논문AI추천